DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
— - 2 Trung Huynh - 1 Eli Lilly - 1 Huynh - 1 Mounjaro - 1 agonism - 1 Lilly hasn't - 1 semaglutide — - 1
Top related locs:
Danish China Guangzhou Canada Mexico
Top related orgs:
Novo Nordisk - 3 European Medicines Agency - 1 Icelandic Medicines Agency - 1 Saxenda - 1 Credit Suisse - 1 Food and Drug Administration - 1 Bloomberg - 1 CNN - 1

Search resuls for: "Semaglutide —"


6 mentions found


☆ European drugs regulator to review Wegovy, Ozempic following reports of suicidal thoughts
  + stars: | 2023-07-10 | by ( Anmar Frangoul | ) www.cnbc.com   time to read: +1 min
The European Medicines Agency said Monday it would undertake a review into a number of drugs used to treat obesity and diabetes after it was reported some patients experienced thoughts of suicide or self-harm. "The review is being carried out in the context of a signal procedure raised by the Icelandic Medicines Agency following three case reports," the EMA said. The EMA said the case reports "included 2 cases of suicidal thoughts, one following the use of Saxenda and one after Ozempic. "The semaglutide-containing medicine Wegovy and the liraglutide-containing medicine Saxenda are authorised for weight loss, together with diet and physical activity," the EMA said. "Suicidal behaviour is not currently listed as a side effect in the EU product information of these medicines," the EMA said.
Organizations: Novo Nordisk, European Medicines Agency, Icelandic Medicines Agency, Saxenda Locations: Danish
☆ Credit Suisse sees Eli Lilly headed higher as Mounjaro users espouse weight loss drug on social media
  + stars: | 2023-06-15 | by ( Christina Cheddar Berk | ) www.cnbc.com   time to read: +3 min
Credit Suisse analyst Trung Huynh has combed through social media and is impressed by the awareness — and demand — for GLP-1 medications such as Eli Lilly 's Mounjaro. Among those observations are reports of other potential benefits that patients taking Mounjaro, or tirzepatide, are seeing. Others taking the drug reported benefits such as a reduction in addiction behaviors such as smoking, drinking, gambling and shopping, among other things. However, this may be a function of patients who are trying to use Mounjaro off-label for obesity, he said. Credit Suisse has an outperform rating on Lilly shares, with a $490 price target, which implies more than 9% upside from where Lilly shares closed Wednesday.
Persons: Trung Huynh, Eli Lilly, Huynh, Mounjaro, agonism, Lilly hasn't, semaglutide —, Lilly, —, Michael Bloom Organizations: Credit Suisse, Food and Drug Administration, Novo Nordisk
☆ Ozempic prices are soaring online in China thanks to unofficial price gouging, with medics scrambling to keep up with demand, reports say
  + stars: | 2023-06-07 | by ( Mia Jankowicz | ) www.businessinsider.com   time to read: +2 min
The Ozempic craze has hit China, causing shortages and price hikes, reports say. Poeple using it to lose weight has caused shortages for Type 2 diabetes patients, doctors say. People in China are rushing to buy up Ozempic for weight loss, causing a boom in prices and leaving shortages for diabetes patients, according to reports. Semaglutide — marketed as Wegovy when used for weight loss in the US — has proven in some studies to be effective in causing weight loss. The platform has also deleted thousands of posts by people sharing their experiences with the drug, CNN reported.
Persons: semaglutide, —, Semaglutide —, It's Organizations: Bloomberg, CNN, China, Huadong, Novo Nordisk Locations: China, Guangzhou, Canada, Mexico
☆ Why buzzy weight-loss drugs such as Ozempic and Wegovy cost so much more in the US
  + stars: | 2023-05-10 | by ( ) www.businessinsider.com   time to read: +4 min
Trendy weight-loss drugs cost much more in the US than in other countries. The price of semaglutide, the drug sold as Wegovy, was three times higher in the US than in the UK. If you're searching for affordable weight-loss drugs, you may be better off looking outside of the US. New weight-loss drugs are unaffordableGetty ImagesWegovy and Ozempic are part of a class of weight-loss drugs known as GLP-1 agonists that have soared in popularity in recent months. Drug prices are highest in the USThe variation in prices for weight-loss drugs across the world is striking.
☆ The 13 startups to watch in the $100 billion market for buzzy new weight-loss drugs like Ozempic
  + stars: | 2023-04-11 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +3 min
Healthcare startups are launching to prescribe weight-loss drugs such as Ozempic. They're chasing what's projected to be a $100 billion market for the drugs. Venture-backed health startups are vying for a piece of the booming market for new prescription drugs designed to help with weight loss. Many startups offering weight-loss drugs have flooded social media platforms with ads for the shots. Insider rounded up 13 venture-backed startups competing for customers in the lucrative GLP-1 weight-loss market, listed from least to most funding raised.
☆ 13 startups vying for a slice of the $100 billion market for buzzy new weight-loss drugs
  + stars: | 2023-04-05 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +3 min
Healthcare startups are launching to prescribe weight-loss drugs such as Ozempic. They're chasing what's projected to be a $100 billion market for the drugs. Venture-backed health startups are vying for a piece of the booming market for new prescription drugs designed to help with weight loss. Many startups offering weight-loss drugs have flooded social media platforms with ads for the shots. Insider rounded up 13 venture-backed startups competing for customers in the lucrative GLP-1 weight-loss market, listed from least to most funding raised.
0 next >>
Total: 6